CH418524A - Reagens zur Durchführung serologischer Testverfahren - Google Patents
Reagens zur Durchführung serologischer TestverfahrenInfo
- Publication number
- CH418524A CH418524A CH122962A CH122962A CH418524A CH 418524 A CH418524 A CH 418524A CH 122962 A CH122962 A CH 122962A CH 122962 A CH122962 A CH 122962A CH 418524 A CH418524 A CH 418524A
- Authority
- CH
- Switzerland
- Prior art keywords
- reagent
- pregnancy
- test
- chorionic gonadotrophin
- suspension
- Prior art date
Links
- 239000003153 chemical reaction reagent Substances 0.000 title claims description 15
- 238000009589 serological test Methods 0.000 title claims description 8
- 238000000034 method Methods 0.000 title claims description 6
- 229960004407 chorionic gonadotrophin Drugs 0.000 claims description 24
- 239000002245 particle Substances 0.000 claims description 20
- 210000002700 urine Anatomy 0.000 claims description 14
- 230000035935 pregnancy Effects 0.000 claims description 13
- 239000000725 suspension Substances 0.000 claims description 12
- 239000004793 Polystyrene Substances 0.000 claims description 10
- 229920002223 polystyrene Polymers 0.000 claims description 10
- 239000007787 solid Substances 0.000 claims description 7
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 claims description 5
- 239000000872 buffer Substances 0.000 claims description 5
- 238000001514 detection method Methods 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 238000012360 testing method Methods 0.000 description 20
- 241000283973 Oryctolagus cuniculus Species 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 11
- 241001465754 Metazoa Species 0.000 description 7
- 239000000427 antigen Substances 0.000 description 6
- 102000036639 antigens Human genes 0.000 description 6
- 108091007433 antigens Proteins 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 4
- 238000001135 Friedman test Methods 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 210000001672 ovary Anatomy 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000010414 supernatant solution Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 230000000890 antigenic effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000004816 latex Substances 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000009597 pregnancy test Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000010425 asbestos Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000012754 cardiac puncture Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000027326 copulation Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000002394 ovarian follicle Anatomy 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 229910052895 riebeckite Inorganic materials 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229960004025 sodium salicylate Drugs 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Reproductive Health (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93839A US3234096A (en) | 1961-03-07 | 1961-03-07 | Compositions and method for performing pregnancy tests |
| US304275A US3309275A (en) | 1963-08-23 | 1963-08-23 | Serological inhibition test for pregnancy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH418524A true CH418524A (de) | 1966-08-15 |
Family
ID=26787953
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH122962A CH418524A (de) | 1961-03-07 | 1962-02-01 | Reagens zur Durchführung serologischer Testverfahren |
Country Status (2)
| Country | Link |
|---|---|
| CH (1) | CH418524A (enrdf_load_stackoverflow) |
| NL (1) | NL131455C (enrdf_load_stackoverflow) |
-
0
- NL NL131455D patent/NL131455C/xx active
-
1962
- 1962-02-01 CH CH122962A patent/CH418524A/de unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NL131455C (enrdf_load_stackoverflow) |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1598832A1 (de) | Auf der Beobachtung eines Agglutinationsvorganges beruhendes Verfahren zum Nachweis von Choriongonadotropin in Koerperfluessigkeiten | |
| DE2529937C2 (de) | Verfahren zur Herstellung eines Latexreagenz für serologische Reaktionen | |
| CH655246A5 (de) | Verfahren zur herstellung von partikeln aus lipoidloeslichen stoffen. | |
| DE2651139C3 (de) | Reagens zur Durchführung eines Direktagglutinationstests zum Schwangerschaftsnachweis und Verfahren zu seiner Herstellung | |
| DE2511698A1 (de) | Testverfahren auf schwangerschaft | |
| DD202178A5 (de) | Verfahren und reagens zur untersuchung von antigen-antikoerper-reaktionen | |
| DE1192367B (de) | Verfahren zur Herstellung eines immunologischen Reagens | |
| DE3105555C2 (enrdf_load_stackoverflow) | ||
| DE2551576C3 (de) | Träger für immunochemische Messungen | |
| DE2163318A1 (de) | Sensibilisierte Zellen, Verfahren zu ihrer Herstellung und ihre Verwendung zur passiven Agglutination | |
| DE2714751C2 (enrdf_load_stackoverflow) | ||
| DE1617734B1 (de) | Verfahren zur Herstellung eines immunologischen Reagens | |
| CH418524A (de) | Reagens zur Durchführung serologischer Testverfahren | |
| DE2521460C2 (de) | Verfahren zum Nachweis von Antikörpern gegen Brucella canis und Antigenreagens | |
| EP0011716B1 (de) | Reagenz zum Nachweis von infektiöser Mononucleose und Verfahren zu seiner Herstellung | |
| DE2054805A1 (de) | Indirekter Hamagglutmationstest bei gleichzeitiger Adsorption heterologer Antikörper | |
| DE2742835A1 (de) | Antigenfraktionen von schistosoma mansoni-eiern, geeignet fuer die untersuchung von schistosomiasis | |
| DE1598928A1 (de) | Verfahren zum Nachweis der infektioesen Mononukleose und Nachweisreagenz | |
| DE1954728A1 (de) | Blutagglutination-Inhibierungstest fuer Viren | |
| DE3689240T2 (de) | Verfahren zum Stabilisieren von Prostatspezifisch-Antigen in natürlichen Matrizen. | |
| DE1280585B (de) | Testreagenz zum Lues-Nachweis | |
| EP0034301A2 (de) | Verfahren zur Bestimmung von Immunkomplexen | |
| DE2618449A1 (de) | Serumdiagnostische zusammensetzung | |
| Race | The suspension stability test in rheumatoid diseases | |
| DE2555188A1 (de) | Immunologische analyse |